Goodwin Procter represented Boston-based Bicara Therapeutics Inc. in a $200 million initial public offering on the Nasdaq. The Goodwin Procter team was led by partners Gabriela Morales-Rivera and Kingsley Taft. Ropes & Gray partner Thomas Danielski was advising the IPO's underwriters, led by Cantor Fitzgerald and Morgan Stanley.
Biotech & Pharmaceuticals
August 23, 2024, 9:20 AM